Most Recent
Juno and Bristol-Myers Squibb suffer losses in Revlimid patent war
Bristol-Myers Squibb 2021-03-25 1:58 pm By Miklos Bolza Sydney
A patent battle between Juno Pharmaceuticals and Bristol-Myers Squibb over the blockbuster drug Revlimid has seen both sides suffer early losses, with a judge dismissing strike out and summary dismissal applications by the drug makers.
J&J units seeks discovery for possible lawsuit over chemotherapy drug
Biopharmalex 2020-12-14 4:24 pm By Cat Fredenburgh
Two units of US drug giant Johnson & Johnson have filed a lawsuit seeking preliminary discovery from Juno Pharmaceuticals for a possible patent lawsuit over a popular chemotherapy drug used to treat blood cancer.
Janssen to expand patent case against Juno over generic HIV drug
Angela McDonald 2020-07-01 4:40 pm By Miklos Bolza Sydney
Drug manufacturer Janssen wants to expand its high stakes case against Juno Pharmaceuticals over its HIV drug Prezista, alleging Juno's plans to launch a generic version of the drug threaten another one of its patents.
Costly IP cases could make Australian courts look bad, Dynastat patent judge says
Biopharmalex 2020-02-26 5:52 pm By Miklos Bolza Sydney
A judge overseeing patent litigation over the painkiller Dynastat has urged the parties to narrow any issues in dispute, saying the excessive amounts of money spent in these types of cases could harm public perception.